Loading…

A Kinetic Model for the Metabolic Interaction of Two Substrates at the Active Site of Cytochrome P450 3A4

In many cases, CYP3A4 exhibits unusual kinetic characteristics that result from the metabolism of multiple substrates that coexist at the active site. In the present study, we observed that α-naphthoflavone (α-NF) exhibited a differential effect on CYP3A4-mediated product formation as shown by an in...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 2001-01, Vol.276 (3), p.2256-2262
Main Authors: Shou, Magang, Dai, Renke, Cui, Dan, Korzekwa, Kenneth R., Baillie, Thomas A., Rushmore, Thomas H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In many cases, CYP3A4 exhibits unusual kinetic characteristics that result from the metabolism of multiple substrates that coexist at the active site. In the present study, we observed that α-naphthoflavone (α-NF) exhibited a differential effect on CYP3A4-mediated product formation as shown by an increase and decrease, respectively, of the carboxylic acid (P2) and ω-3-hydroxylated (P1) metabolites of losartan, while losartan was found to be an inhibitor of the formation of the 5,6-epoxide of α-NF. Thus, to address this problem, a kinetic model was developed on the assumption that CYP3A4 can accommodate two distinct and independent binding domains for the substrates within the active site, and the resulting velocity equations were employed to predict the kinetic parameters for all possible enzyme-substrate species. Our results indicate that the predicted values had a good fit with the experimental observations. Therefore, the kinetic constants can be used to adequately describe the nature of the metabolic interaction between the two substrates. Applications of the model provide some new insights into the mechanism of drug-drug interactions at the level of CYP3A4.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M008799200